Actively Recruiting
Threat-related Sensory Cortical Disinhibition and SPA Pathology in Posttraumatic Stress Disorder (PTSD) Using Transcranial Alternating Current Stimulation (tACS) and Transcranial Random Noise Stimulation (tRNS)
Led by The University of Texas Health Science Center, Houston · Updated on 2025-09-12
160
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
T
The University of Texas Health Science Center, Houston
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating the underlying brain mechanisms related to posttraumatic stress disorder (PTSD) using a neuroscience approach. The study aims to understand how abnormal sensory cortex and amygdala-prefrontal cortex activity contribute to PTSD symptoms. It also evaluates how Transcranial Alternating Current Stimulation (tACS), a brain stimulation technique, might influence neural networks and reduce anxiety symptoms like heightened arousal and hypervigilance. The study involves 160 participants, including 80 healthy individuals and 80 people with PTSD, who are randomly assigned to one of three groups. One group receives tACS at their individual alpha brainwave frequency, another receives sham (placebo) stimulation, and the third receives transcranial random noise stimulation (tRNS) as an active control. Stimulation is applied using electrodes placed in an EEG cap for 10 to 40 minutes. During the study, participants complete tasks involving visual search and smell detection with both threatening and neutral stimuli, while brain activity is recorded using EEG and fMRI before and after stimulation. Participants will take part in brain scans and behavioral assessments during the sessions. Researchers will measure changes in brain electrical activity, blood flow in brain regions, accuracy and speed in visual and smell tasks, and physiological responses like skin conductance before and after stimulation. The study includes monitoring for safety and evaluates how brain stimulation affects neural oscillations and related behaviors. Participation lasts through the stimulation sessions and immediate post-stimulation assessments.
CONDITIONS
Brief Title
A Neurosensory Account of Anxiety and Stress (Study 2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Right-handed
- Normal or corrected-to-normal vision and normal sense of smell
- Between 18 and 50 years old
- Meet tACS screening criteria, including no serious head injury or loss of consciousness
- Diagnosis of PTSD for patient participants
- Stable psychotropic medication use for at least 2 months if applicable
- Abstain from substance use for 48 hours before the experiment if mild substance use disorder or occasional use
You will not qualify if you...
- History of major medical illness (e.g., cancer, metabolic syndrome, cardiovascular disease, inflammatory disorders) or neurological disorder (e.g., seizure, stroke, Parkinson's disease)
- Concurrent Axis I diagnosis excluding depression, anxiety, and mild substance use disorder for patients
- History of DSM-5 Axis I disorder or current psychoactive medication use for healthy controls
- Severe psychiatric instability or active suicidal/homicidal behavior
- Head trauma with unconsciousness lasting more than 5 minutes
- Regular consumption of 3 or more alcoholic drinks daily
- Inability to abstain from substance use or sleep medication for 48 hours before scanning
- Use of calcium channel or alpha-blocker medications without ability to stop for 48 hours
- Failed urine drug screening test
- Pregnancy detected by urine test
- Presence of electrically, magnetically, or mechanically activated implants (e.g., pacemakers)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single session lasting 10 to 40 minutes
Participants receive transcranial electrical stimulation via an EEG cap using one of the following: Transcranial Alternating Current Stimulation (tACS), Sham tACS, or Transcranial Random Noise Stimulation (tRNS). Stimulation lasts between 10 to 40 minutes with electrodes placed on the scalp.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
W
Wen Li, PhD
J
Jada Malveaux, MA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here